References
- Alaedini A, Green PHR. Autoantibodies in celiac disease. Autoimmunity 2008; 41: 19–26
- Esposito C, et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002; 51: 177–181
- Dieterich W, et al. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut 2003; 52: 1562–1566
- Seissler J, et al. Autoantibodies from patients with coeliac disease recognise distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol 2001; 125: 216–221
- Nunes I, et al. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997; 136: 1151–1163
- Hansson T, et al. Transforming growth factor-beta and tissue transglutaminase expression in the small intestine of children with coeliac disease. Scand J Immunol 2002; 56: 530–537
- Nilsen EM, et al. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995; 37: 766–776
- Mention J, et al. Interleukin 15: A key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125: 730–745
- Daum S, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibition of metalloproteinase-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999; 44: 17–25
- Moss SF, et al. Increased small intestinal apoptosis in coeliac disease. Gut 1996; 39: 811–817